Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for prevention of contrast-induced nephropathy
IRCT2015102624713N1Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pentoxifylline in contrast-induced nephropathy (CIN), sponsored by Zahedan University of Medical Sciences. Started Jan 2016; status: completed.
02
Drugs
pentoxifylline
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT2015102624713N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015102624713N1.